Curanex Pharmaceuticals Inc

CURX · Nasdaq · SIC 2834: Pharmaceutical Preparations
18
SEC Filings

Business Summary

PART I ITEM 1. D escription of Business Overview Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients lives by harnessing the power of natural substances. We are dedicated to discovering, developing and commercializing botanical medicines for treating patients with immune and i...

Next Earnings

Q2 FY2026 — expected 2026-09-23

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCURXdiscussed_in_filing Cybersecurity
topic_mentionCURXdiscussed_in_filing Trusted Computing
topic_mentionCURXdiscussed_in_filing Blockchain & Crypto
topic_mentionCURXdiscussed_in_filing Supply Chain
topic_mentionCURXdiscussed_in_filing Regulation
topic_mentionCURXdiscussed_in_filing Healthcare & Bio
topic_mentionCURXdiscussed_in_filing Sovereign & Government
topic_mentionCURXdiscussed_in_filing Cybersecurity
topic_mentionCURXdiscussed_in_filing Trusted Computing
topic_mentionCURXdiscussed_in_filing Blockchain & Crypto
topic_mentionCURXdiscussed_in_filing Supply Chain
topic_mentionCURXdiscussed_in_filing Regulation
topic_mentionCURXdiscussed_in_filing Healthcare & Bio
topic_mentionCURXdiscussed_in_filing Sovereign & Government
topic_mentionCURXdiscussed_in_filing Cybersecurity
topic_mentionCURXdiscussed_in_filing Trusted Computing
topic_mentionCURXdiscussed_in_filing Blockchain & Crypto
topic_mentionCURXdiscussed_in_filing Supply Chain
topic_mentionCURXdiscussed_in_filing Regulation
topic_mentionCURXdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001493152-26-013677EDGAR59K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-172025-09-300001493152-25-023710EDGAR14K words
2025-09-092025-06-300001493152-25-012880EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001493152-26-014815EDGAR1K words
2026-03-060001493152-26-009155EDGAR—
2026-01-050001493152-26-000358EDGAR—
2025-11-060001493152-25-021028EDGAR—
2025-09-290001493152-25-015986EDGAR—
2025-09-120001493152-25-013167EDGAR—
2025-08-270001493152-25-012404EDGAR—
2025-08-260001493152-25-012316EDGAR—

18 total filings indexed. 7 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0002025942
TickerCURX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f307175f0fa626cb0688a9de2887939031f03767331a8077561fbe3fb3a067b8
parent: efa020abddf67772af00c805beda1766849c048a2ef5948f65efe6bb59f8c3a7
content hash: a3aec7f3f168a2df5df81ed906bafc1de6ff7f241c22dbe51205a27197b42fdb
signed: 2026-04-13T04:44:33.711Z
sources: 3 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf